We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Increased Exercise in Later Life Also Reduces Mortality Risk

By HospiMedica International staff writers
Posted on 17 Mar 2009
A new study has found that men who increase their level of exercise later in life can bring their mortality risk into line with their counterparts who have constantly exercised.

Researchers at Uppsala University (Sweden) conducted a study of 2,205 men who were aged 50 years between 1970 and 1973, and who had been followed up at 60, 70, 77, and 82 years to examine how a change in the level of physical activity after middle age influences mortality, and to concomitantly compare the results of an increase in level exercise to the effect of smoking cessation. More...


The researchers found that in groups with low, medium, and high levels of physical activity, the absolute mortality rate was 27.1, 23.6 and 18.4 per 1,000 person-years, respectively. Men who increased their level of exercise between the ages of 50 and 60 did not have a lower mortality rate for the first five years, but after 10 years their risk of dying was the same as that of men who had been in the high physical activity group all along. The study was published online on March 5, 2009 in BMJ.

"An increase in physical activity has the same impact on lowering mortality rate in the long term as smoking cessation. Thus, efforts for promotion of physical activity, even among middle-aged and older men, are important,” said lead author Liisa Byberg, Ph.D., and colleagues of the department of surgical sciences. "The effects in other age groups and in women need to be studied. Mechanisms and reasons for an active choice to change physical activity are not fully understood.”

Related Links:
Uppsala University




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.